Detection of autoantibodies in patients with ON.

<p>ANA: antinuclear antibody, SSA and SSB: extractable nuclear antigen antibodies, RF:rheumatoid factor,ACL: anticardiolipin antibody, AQP-4: aquaporin-4; A-ds DNA: anti-double-stranded DNA antibody;</p><p>* = <i>p</i><0.05; ** = <i>p</i><0.01. <i>p</i>1 = RON vs. BON; <i>p</i>2 = RON vs. ION; <i>p</i>3 = BON vs. ION.</p

Differences between patients with positive SSA/SSB and negative SSA/SSB.

<p>* = <i>p</i><0.05; ** = <i>p</i><0.01.</p

Epidemiologic and Disease Characteristics of Patients with three types of ON.

<p>* = P<0.05; ** = P<0.01. P1 = RON vs BON; P2 = RON vs ION; P3 = BON vs ION;</p

Disease Characteristics of ON Patients combined with SS.

<p>Neg: negative; N: not relapse to NMO; None: none abnormal signals; G:glucocorticoid; IS: immunosuppressive.</p

Diagnosis of different rheumatologic diseases.

<p>AS: Ankylosing spondylitis; RM: Rheumatoid; BD: Behcet’s disease; WG: Wegner’s granulomatosis; SLE: Systemic lupus erythematosus; ACA: Anticardiolipin antibody syndrome; SS: Sjogren’s syndrome.</p><p>* = <i>p</i><0.05; ** = <i>p</i><0.01. <i>p</i>1 = RON vs. BON; <i>p</i>2 = RON vs. ION; <i>p</i>3 = BON vs. ION.</p

Mean FA values of the whole and posterior intraorbital optic nerve in the NMO subgroups and NC.

<p>(BI, biocular impairment; MI, monocular impairment; NA, normal-appearing; NC, normal control; whole, whole intraorbital optic nerve; posterior, posterior intraorbital optic nerve).</p